個股熱度排行 | 10月19日港股盤前
根據uSMART輿情監測數據,從18日晚間到19日港股盤前時間段,市場關注指數最高的2只股票是浙江世寶、金輝集團。
10月19日—港股關注排行TOP2

浙江世寶

關注度第一爲浙江世寶,該股上個交易日收盤上漲1.45%,報於1.40港元。近5個交易日累計上漲4.48%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
浙江世寶擬非公開發行A股股票募資不超11.8億元
浙江世寶擬定增募資不超過11.8億元人民幣
金輝集團

關注度第二爲金輝集團,該股上個交易日收盤持平,報於1.15港元。近5個交易日累計持平。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
金輝集團倆附屬擬合共出售兩艘船舶 總代價爲3450萬美元
金輝集團擬3450萬美元出售兩艘船舶
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.